Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine Read more about Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program Read more about BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine Read more about Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine Read more about Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine Read more about Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine
BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine Read more about BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2 Read more about Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older Read more about U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19 Read more about Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
